Stimulation of the Larynx to Treat Unexplained Chronic Cough
NCT05273190 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-08-11
Summary
Researchers will test the effect of non-invasive vibrotactile stimulation of the larynx on symptom severity of unexplained chronic cough.
Conditions
Interventions
- DEVICE
-
Vibrotactile Stimulation
Small electric motors, similar to a vibrating cell phone or gaming joystick, deliver vibration to the throat. Participants will assess cough symptoms throughout the study period.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Stephanie Misono · University of Minnesota
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 88 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-13
- Primary Completion
- 2027-07-30
- Completion
- 2027-12-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough
NCT02993822 ·Status: COMPLETED ·Phase: PHASE2
-
ATP and P2X3 Receptor in Chronic Cough
NCT05713019 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough
NCT04562155 ·Status: COMPLETED ·Phase: PHASE2
-
GSK2339345 Hypertussive Challenge Study
NCT01899768 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Treatments for Dry or Productive Cough
NCT07330856 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough
NCT05733533 ·Status: COMPLETED ·Phase: PHASE2
-
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
NCT05599191 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Comprehensive Evaluation of the Impact of ATP on Laryngeal Symptoms, Hypersensitivity and Function
NCT05570981 ·Status: UNKNOWN
-
A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough
NCT05660850 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough
NCT06213363 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough
NCT01703923 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)
NCT04193202 ·Status: COMPLETED ·Phase: PHASE3
-
Lidocaine: Effect of Lidocaine in Chronic Cough
NCT01252225 ·Status: COMPLETED ·Phase: PHASE4
-
Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection
NCT01597349 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19
NCT05808400 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
ATP Level and Cough Sensitivity to ATP in Subjects With Refractory/Unexplained Chronic Cough
NCT05265871 ·Status: COMPLETED
-
Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)
NCT02476890 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of S-600918 in Adults With Refractory Chronic Cough
NCT04110054 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Oral Procaterol on Postinfectious Persistent Cough
NCT02349919 ·Status: UNKNOWN ·Phase: NA
-
The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges
NCT07085975 ·Status: RECRUITING ·Phase: PHASE1
-
TruFreeze™ Airway Obstruction: TAO STUDY
NCT01903850 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)
NCT03449134 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Mechanism of Cough Hypersensitivity
NCT02591550 ·Status: UNKNOWN
-
An 8-Week Refractory Chronic Cough Study (MK-7264-021)
NCT02612623 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT04708782 ·Status: COMPLETED ·Phase: PHASE3